Hepion Pharmaceuticals Further more Strengthens Board with Appointments of Completed Biopharmaceutical Executives, Mr. Anand Reddi and Dr. Kaouthar Lbiati
Hepion Pharmaceuticals, Inc.EDISON, N.J., June 28, 2022 (World NEWSWIRE) -- Hepion Prescription drugs, Inc. (NASDAQ:HEPA), a medical mid-stage biopharmaceutical enterprise...